Combined with the observation that LINC01198’s activation in tumor cells increased IFN-γ, GzmB, and type I–related cytokine (i.e., CXCL10 and TNF-α) secretions, we hypothesized that LINC01198 regulated IFN signaling pathways in cancer cells. The gene discussed is CXCL10; the disease is neoplasm.